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Abstract
Background and Objective: Dehydrated fruit and vegetable concentrates provide an accessible form of
phytonutrient supplementation that may offer cardioprotective effects. This study assessed the effects of two
blends of encapsulated juice powder concentrates (with and without added berry powders) on endothelial
function in persons with metabolic syndrome, a risk factor for type 2 diabetes and cardiovascular disease.
Methods: Randomized, double blind, placebo controlled crossover clinical trial with three treatment arms. 64
adults with metabolic syndrome were enrolled and received 8-week sequences of each blend of the concentrates
and placebo. The primary outcome measure was change in endothelial function (assessed as flow-mediated
dilatation of the brachial artery) 2 hr after consuming a 75 g glucose load, after 8-weeks of daily consumption
(sustained) or 2 hr after consumption of a single dose (acute). Secondary outcome measures included plasma
glucose, serum insulin, serum lipids, and body weight.
Results: No significant between-group differences in endothelial function with daily treatment for 8 weeks were
seen. No other significant treatment effects were discerned in glucose, insulin, lipids, and weight.
Conclusion: Encapsulated fruit and vegetable juice powder concentrates did not alter insulin or glucose measures
in this sample of adults with metabolic syndrome.
Trial Registration: clinicaltrials.gov NCT01224743
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Background
Among non-pharmacologic approaches to cardiovascu-
lar disease prevention, regular consumption of fruit and
vegetables demonstrates a dose-response effect in redu-
cing risk for coronary heart disease [1,2]. Green leafy
vegetables and foods high in vitamin C content appear
to have the strongest relationship to cardiac risk reduc-
tion [1]. Dark berries have been shown to improve
blood pressure, platelet function, vascular function, and
lipids likely due to the relatively high levels of antioxi-
dant polyphenols [3]. Phytonutrients in fruits and vege-
tables, including flavonoids [4,5] may have specific
cardioprotective effects partially mediated through favor-
able effects on endothelial function [6].
Despite multiple public health measures designed to
increase fruit and vegetable consumption [7,8], popula-
tion intake levels are suboptimal [9,10]. Barriers to wide-
spread increases in fruit and vegetable intake include
cost and lack of access in medically underserved areas
[7]. Dehydrated fruit and vegetable juice concentrates,
available in capsule form, provide an accessible form of
phytonutrient supplementation that may provide similar
cardioprotective effects.
Because of the strong correspondence between periph-
eral and coronary endothelial responses [11], measure-
ment of endothelial-dependent flow-mediated dilatation
of the brachial artery with the use of high-resolution
ultrasound scanning has become a standard research
assessment method [12]. Endothelial function may be
acutely impaired by consuming a glucose load [13];
therefore, various vasculoprotective [14,15] and
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endothelial dysfunction induced by hyperglycemia.
This study aimed to assess the effects of commercially
available encapsulated fruit and vegetable juice powder
concentrates (Juice Plus+) on post-glucose challenge
endothelial function and cardiac risk markers in patients
with metabolic syndrome, a constellation of risk factors
directly promoting atherosclerosis [17]. We hypothe-
sized that encapsulated fruit and vegetable concentrates
can provide cardioprotective benefits similar to the
effects of regular consumption of whole fruits and
vegetables.
Methods
Ethics Statement
The study protocol and consent form were approved
by the Griffin Hospital (Derby, CT) Institutional
R e v i e wB o a r da n dt h eY a l eU n i v e r s i t y( N e wH a v e n ,
CT) Human Investigation Committee and conducted
in accordance with the Declaration of Helsinki. Writ-
ten informed consent was obtained, and all subjects
received nominal monetary compensation for their
participation.
Participants
Subjects were female or male, 18 years of age or older
with metabolic syndrome [18]. Eligible subjects were
nonsmokers (as smoking impairs endothelial function
[19]), not taking any other vitamins or dietary supple-
ments, and able to have blood pressure measured bilat-
erally at the brachial artery. Subjects were excluded with
any unstable medical condition that would limit the
ability to participate fully in the trial. Subjects were also
excluded if using insulin, glucose sensitizing medication,
and vasoactive medications (including glucocorticoids,
antineoplastic agents, psychoactive agents, or bronchodi-
lators). Other exclusion criteria included rheumatologic
disease requiring regular use of NSAIDs or alternative
medications, preexisting cardiovascular disease, or a
diagnosed eating disorder.
Metabolic syndrome was defined using the Interna-
tional Diabetes Federation criteria [18] of: waist circum-
ference of ≥ 94 cm (males) or ≥ 80 cm (females) plus
any two of the following: (a) blood pressure ≥ 130/85 or
taking antihypertensive medication, (b) fasting plasma
glucose (FPG) > 100 mg/dL, (c) serum triglycerides
(TG) > 150 mg/dL, (d) high-density lipoprotein (HDL) <
40 mg/dL in men, and < 50 mg/dL in women. Subjects
on lipid lowering medication were assumed to meet cri-
teria for (c) and (d) above, though required to have a
stable dose for at least three months and willing to
refrain from taking medication for 12 hours prior to
endothelial function assessment.
Study Design and Interventions
This study was a randomized, double blind, placebo
controlled crossover clinical trial with three treatment
arms designed to assess the effects of 8 weeks of daily
ingestion of two encapsulated fruit and vegetable juice
powder concentrates (Juice Plus+) vs. placebo. The two
blends were chosen to further assess whether the addi-
tion of berry powders (Blend 1) would result in differ-
ential effects compared to a general blend of fruits and
vegetables (Blend 2). Blend 1 consisted of a combina-
tion of fruit, vegetable, and berry mixtures containing
7.5 mg b-carotene, 276 mg vitamin C, 72 mg vitamin
E (RRR-a-tocopherol), 780 μg folate, and 80 mg
calcium [20,21]. Blend 2 consisted of a combination of
fruit and vegetable mixtures containing 7.5 mg
b-carotene, 234 mg vitamin C, 30 mg vitamin E (RRR-
a-tocopherol), 420 μg folate, and 60 mg calcium [21].
A description of the blends used in the study are in
Table 1.
For the initial assignment, subjects were randomized
to Blend 1, Blend 2, or placebo. As the pharmacoki-
netics of the tested blends are unknown, our design
incorporated an 8-week washout period with no inter-
vention after completing the initial treatment assign-
ment. Subjects were then crossed-over to one of the two
remaining assignments. Following 8-weeks of sustained
intervention in the second assignment and an 8-week
washout period, subjects then crossed-over to the
remaining treatment assignment for 8-weeks followed
by a final 8-week washout period. Subjects were evalu-
ated on six occasions during the study: baseline, at the
completion of each of the three sustained treatment
assignments, and following two washout periods (see
Figure 1)
Table 1 Description of Interventions
Blend 1 Blend 2
Consisted of juice powder concentrates containing: Apple, Orange,
Pineapple, Cranberry, Peach, Acerola cherry, Papaya, Carrot, Parsley, Beet,
Kale, Broccoli, Cabbage, Spinach, Tomato
With added berry powders containing:
Concord grape, Blueberry, Cranberry, Blackberry, Bilberry, Raspberry, Red
currant, Black currant, Elderberry, Green tea, Ginger root, Grape seed,
Artichoke
Consisted of juice powder concentrates containing: Apple, Orange,
Pineapple, Cranberry, Peach, Acerola cherry, Papaya, Carrot, Parsley, Beet,
Kale, Broccoli, Cabbage, Spinach, Tomato
Source: Natural Standard Database: www.naturalstandard.com
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Page 2 of 8Subjects were instructed to take three capsules twice
daily for a total of six capsules per day (4.5 grams). Pla-
cebo capsules were provided by the study sponsor and
were identical in appearance to active treatments to
ensure blinding. Subjects continued consuming their
usual diet; no dietary advice or guidance was provided
during the course of the study.
Recruitment: Screening commenced in December
2004. Of the 632 persons screened for eligibility, 534 did
not meet eligibility criteria, 5 refused to participate, and
29 were not randomized for other reasons (see Figure
1). Enrollment continued until October 2006. 64 sub-
jects (52% female, mean age 56.9 years) were rando-
m i z e dt os e q u e n c e so fB l e n d1 ,B l e n d2 ,a n dp l a c e b o .
Subjects received the intervention between July 2005
and October 2007. Of the enrolled subjects, 48 com-
pleted at least 1 time point and 44 completed the entire
trial (see Figure 1). Pill count data was available for 75%
of all supplement bottles dispensed; 84% of these
demonstrated compliance of over 80%.
Primary outcome measure
Endothelial function was assessed as flow-mediated dila-
tation (FMD) of the brachial artery using standard pro-
cedures [22]. In brief, FMD was measured noninvasively
in the right brachial artery with a high-frequency ultra-
sound (Sonos 4500; Phillips Medical Systems, Andover,
MA) in accordance with published guidelines [12]. Mea-
sures of vessel diameter and flow velocity were obtained
by a single dedicated vascular clinical research specialist
(YM) blinded to subject treatment status. Repeat scans
were obtained at 15, 60, and 120 seconds after deflation.
At each scanning interval, both cross-sectional vessel
diameter and flow velocity were recorded. In addition to
brachial diameter at 60 seconds after cuff release, flow
after cuff deflation within the first 15 seconds was used
as an indicator of stimulus strength; hyperemic flow
being the stimulus for endothelial reactivity. To account
for potential variability in stimulus strength, FMD was
divided by flow at 15 seconds after cuff deflation to cre-
ate a stimulus-adjusted response measure.
Normal FMD in young, healthy subjects is typically
> 10% [23]. Impaired FMD is generally < 10%; Su et
al. reported mean FMD values of 10.68 in those with
normal glucose tolerance, 8.86 in patients with
impaired glucose tolerance, and 5.27 in type 2 dia-
betes mellitus [24].
The primary outcome measures were the difference in
FMD between the two blends of supplements and pla-
cebo following a 2-hour oral glucose tolerance test
(OGTT) after 8 weeks of treatment.
Secondary Outcome Measures
Change in the fasting (unchallenged) FMD after 8 weeks
on active treatment and placebo assignments, the differ-
ence in FMD between Blend 1 and Blend 2, weight,
lipid panel, and serum insulin. Acute (single dose)
effects on endothelial function and plasma glucose were
assessed by consuming the supplements concurrently
with a 75 g glucose challenge load and assessing FMD
after two hours.
Outcomes were assessed and laboratory measures
were collected and analyzed at Griffin Hospital (Derby,
CT) as routine clinical samples following each visit.
Randomization
Subjects meeting eligibility criteria and enrolling in the
study were randomized by the study sponsor to treat-
ment sequence using the web site Randomization.com
(http://www.randomization.com). The sponsor provided
coded bottles for each subject containing their daily cap-
sules. Subjects were enrolled and assigned to interven-
tions by the study coordinator. All study personnel and
subjects were blinded to treatment assignment through-
out the duration of the intervention.
Statistical Analysis
Statistical analysis was conducted using SAS software
(Version 9.1, SAS Institute, Cary, NC, USA). Repeated
measures ANOVA were performed to compare the
means of both dependent and independent variables at
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Figure 1 Flow of participants in the trial.
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Page 3 of 8baseline and after each washout period between the
three treatment groups. To adjust for any potential car-
ryover effect following washout, treatment sequence
(timing of each treatment) was entered as a control vari-
able in multivariable analysis.
Analysis was by intention-to-treat. Missing individual
data was addressed by the last observation carried for-
ward method. Data were assessed for normality prior to
analysis. Consistent with guidelines from the Interna-
tional Brachial Artery Reactivity Task Force [12], a sam-
ple size of 48 individuals, allowing for 20% attrition and
non-adherence, was predicted to provide 80% power to
detect a minimal clinically important difference of 3.0%
in post-glucose load FMD between intervention and pla-
cebo groups following 8 weeks of daily treatment, as
well as adjusting for multiple comparisons for three
pair-wise comparisons (two-tailed a = 0.05).
Ancillary Analyses
Per-protocol analysis included subjects that completed
at least one treatment assignment. Paired t-tests were
used to compare baseline measures of FMD and plasma
analyses to the values obtained at the end of each wash-
out period (within-group analyses).
Results
Baseline characteristics of the study participants are pro-
vided in Table 2. All subjects were overweight; the mean
body-mass index (BMI) of participants at baseline was
31.8 kg/m
2. Endothelial function was partially
compromised with an average FMD of 8% at baseline.
Subjects were pre-diabetic [25] with a mean FPG of 115
mg/dL.
Endothelial Function
Compared to placebo, no significant differences (P >
0.05) were seen in FMD change between baseline and
8-weeks in subjects consuming Blend 1 or Blend 2
(Table 3). Findings persisted after controlling for the
variability of the strength of the stimulus that deter-
mines vasodilatation (Table 2). No significant deteriora-
tion in endothelial function was seen in any group after
consuming the glucose load (Table 3). A random sample
of 20 FMD measurements were reanalyzed; the correla-
tion (Pearson’s r) between the initial and second assess-
ment values was 99%.
Serum Measures
No significant changes in serum insulin were seen in
either intervention group between baseline and 8-weeks
compared to placebo (P>0.05). Furthermore, no signifi-
cant differences were seen between Blend 1, Blend, 2,
and placebo in FPG and total cholesterol (all P>0.05)
(Table 3).
Weight
Body weight did not change in any group after eight
weeks.
Ancillary Analyses
Per-protocol analyses consisting of subjects that com-
pleted the entire intervention (n = 27-37) did not reveal
any major differences from the intention-to-treat analy-
sis. Furthermore, analyses of highly compliant subjects
(>80% compliance) and the combination of compliant
subjects completing the trial did not find any significant
treatment effects of either blend (Table 4). Acute (single
dose) effects of Blend 1 trended towards a significant
improvement in endothelial function two hours after
consumption of a 75-g glucose load when compared to
baseline (Blend 1: 1.1 ± 3.7%, P = 0.0549). No significant
between-group differences were found. No effects of
gender or age were found.
Adverse Effects
No adverse effects related to the intervention were seen
during the course of the study.
Discussion
Daily supplementation with these two blends of
encapsulated fruit and vegetable juice powder concen-
trates did not improve endothelial function or other car-
diac risk measures in this population of adults with
metabolic syndrome; no significant between-group
Table 2 Baseline Values (n = 60)
Variable Values
(mean ± SD)
Demographics
Female (n,%) 31 (52%)
Age 56.9 ± 11.2
Endothelial Function
Flow-mediated dilatation, % 8.00 ± 3.70
Stimulus-adjusted response measure 0.11 ± 0.21
Serum Measures
Insulin, pmol/L 346.56 ± 225.71
Fasting plasma glucose, mmol/L 6.37 ± 1.86
Anthropometric Measures
Body Weight, kg 89.00 ± 18.80
Body Mass Index, kg/m
2 31.80 ± 5.60
Lipid Panel
Total Cholesterol, mmol/L 5.28 ± 1.00
High Density Lipoprotein (HDL), mmol/L 1.09 ± 0.25
Total Cholesterol/HDL 5.10 ± 1.40
Triglycerides, mmol/L 2.00 ± 1.16
Low Density Lipoprotein (LDL), mmol/L 3.33 ± 0.91
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Page 4 of 8differences were seen. Contrary to expectation, acute
glucose loading did not induce endothelial dysfunction.
The acute administration of fruit and vegetable blends
in combination (Blend 2) appeared to augment endothe-
lial function.
Previous research in fruit and vegetable juice powder
concentrates demonstrated significant improvements in
serum antioxidant levels after four weeks [26] or 60
days [21] of daily supplementation. Despite compelling
epidemiological [27-32] and preclinical [33,34] evidence
supporting the use of antioxidant supplements, several
large randomized trials [35-41] have not demonstrated
significant benefits of antioxidant supplements on car-
diac risk, with some possibility of increased risk [42-44].
A common hypothesis for these apparently discrepant
findings is that residual confounding occurred; that is,
people that use dietary supplements also tend to incor-
porate cardioprotective lifestyle habits such as a prudent
diet and regular exercise regimens at a higher preva-
lence than persons who do not regularly use dietary
supplements [45].
A previous trial demonstrated positive effects of four
weeks of supplementation with the same phytonutrient
blends used in our study on FMD in reducing the
Table 3 Change in Outcome Measures after 8 weeks (Intention-to-treat analysis) (n = 55-60)
Variable Blend 1
(mean ± SD)
Blend 2
(mean ± SD)
Placebo
(mean ± SD)
Endothelial Function
Flow-mediated dilatation, % 0.70 ± 3.70 0.70 ± 3.80 0.60 ± 3.70
Stimulus-adjusted response measure -0.02 ± 0.23 -0.02 ± 0.21 -0.03 ± 0.21
Flow-mediated dilatation, % (acute effects) 1.1 ± 3.70 0.7 ± 3.5 -0.3 ± 5.4
Serum Measures
Insulin, pmol/L 68.06 ± 311.83 18.06 ± 213.21 15.97 ± 202.79
Fasting plasma glucose, mmol/L 0.03 ± 1.44 0.16 ± 1.47 0.38 ± 1.58
Anthropometric Measures
Body Weight, kg 0.40 ± 2.20 0.30 ± 2.80 0.40 ± 2.20
Body Mass Index, kg/m
2 0.10 ± 0.80 0.10 ± 1.00 0.10 ± 0.80
Lipid Panel
Total Cholesterol, mmol/L 0.08 ± 0.47 0.08 ± 0.60 0.03 ± 0.52
High Density Lipoprotein (HDL), mmol/L 0.04 ± 0.17 0.04 ± 0.12 0.06 ± 0.15
Total Cholesterol/HDL -0.10 ± 0.60 -0.10 ± 0.80 -0.30 ± 0.70
Triglycerides, mmol/L 0.02 ± 0.64 -0.01 ± 0.71 -0.13 ± 0.68
Low Density Lipoprotein (LDL), mmol/L -0.02 ± 0.53 0.08 ± 0.62 0.02 ± 0.53
p > 0.05 for all pairwise comparisons
Table 4 Change in Outcome Measures after 8 weeks (For subjects with at least 80% compliance) (n = 27-37)
Variable Blend 1
(mean ± SD)
Blend 2
(mean ± SD)
Placebo
(mean ± SD)
Endothelial Function
Flow-mediated dilatation, % 0.60 ± 4.30 1.00 ± 3.40
1 0.60 ± 4.20
Stimulus-adjusted response measure -0.04 ± 0.33 -0.04 ± 0.28 -0.05 ± 0.28
Serum Measures
Insulin, pmol/L 65.28 ± 362.53 -29.17 ± 232.66 20.14 ± 225.71
Fasting plasma glucose, mmol/L 0.16 ± 1.75 0.11 ± 1.69 0.07 ± 1.61
Anthropometric Measures
Body Weight, kg 0.90 ± 2.90 0.20 ± 2.50 0.40 ± 2.00
Body Mass Index, kg/m
2 0.30 ± 0.90 0.00 ± 0.80 0.10 ± 0.70
Lipid Panel
Total Cholesterol, mmol/L 0.10 ± 0.62 0.04 ± 0.49 0.01 ± 0.62
High Density Lipoprotein (HDL), mmol/L 0.04 ± 0.21 0.06 ± 0.15 0.10 ± 0.17
Total Cholesterol/HDL -0.10 ± 0.70 0.00 ± 0.80
1 -0.40 ± 0.80
Triglycerides, mmol/L 0.03 ± 0.71 0.24 ± 0.60 -0.19 ± 0.87
Low Density Lipoprotein (LDL), mmol/L -0.04 ± 0.71 0.11 ± 0.55 -0.01 ± 0.74
1 p = 0.02 as compared to placebo;
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three hours after consumption of the meal [46]. Our
subjects did not consume a high-fat meal prior to
endothelial function assessment; rather they consumed a
75-g glucose load 2-hours prior to acute assessment.
The literature is mixed regarding the effects of a glucose
load on endothelial function; some studies have found
deterioration [13,47-50] while others have found no
change [51-53] in endothelial function following con-
sumption of a glucose load. We expected that a glucose
challenge load would impair endothelial function similar
to the impairments seen with a high-fat meal. Our sub-
jects, however, did not experience a significant change
in endothelial function following the consumption of a
75-gram glucose load (Table 4). Thus, it is possible that
acute effects of the fruit and vegetable juice powder
concentrates were attenuated in light of relatively unim-
paired vascular function, or that supplementation with
these concentrates provided a protective effect on the
vasculature attenuating any deleterious effects of the
glucose load. A somewhat surprisingly normal mean
baseline FMD and a lack of overt degradation in
response to a glucose challenge in our subjects may
have mitigated against any observable treatment effect.
It is possible that eight weeks of intervention was too
s h o r ti nd u r a t i o nt od e m o n s t rate significant sustained
effects in endothelial function and cardiac risk markers.
However, in our own lab, we have demonstrated signifi-
cant improvements two hours after acute ingestion [22],
as well as, after six weeks of daily consumption of cocoa
[54] containing antioxidant flavonoids. Furthermore, a
recent trial of whole fruits and vegetables (1-6 servings/
day) demonstrate significant benefits in endothelial
function measured by venous occlusion plethysmogra-
phy in a dose-response manner in hypertensive patients,
leading to a 6.2% improvement in endothelium-depen-
dent forearm blood flow after eight weeks [55].
Whole fruits and vegetables contain significant
amounts of dietary fiber, demonstrated to have cardio-
protective effects [56] and the ability to reduce coronary
heart disease events [2] and improve endothelial func-
tion [55]. The supplements used in this trial were
encapsulated fruit and vegetable juice powder concen-
trates with minimal fiber. It is possible that dietary fiber
mediates the beneficial effects of fruits and vegetables
on endothelial function and cardiovascular risk. Further-
more, fiber in the diet promotes satiety [57,58]; thus
persons adding fruits and vegetables to their routines
may be displacing the consumption of other foods that
promote weight gain and increase cardiac risk. The
small capsules (4.5 g in six capsules) used in this study
a r eu n l i k e l yt oa f f e c ts a t i e t ya n dt h u sd i s p l a c et h ec o n -
sumption of atherogenic foods.
Strengths of this study include a crossover design
increasing statistical power and a well-tolerated, com-
mercially available intervention. Limitations of this study
include the lack of antioxidant biomarkers to corrobo-
rate serum antioxidant levels with supplement consump-
tion. It is possible that subjects with low serum
antioxidant levels may benefit from supplementation
more than persons with normal or supranormal levels.
Other limitations include a relatively homogenous sam-
ple; largely Caucasian in a suburban community setting,
as well as a lack of data regarding dietary, exercise
habits, and alcohol intake that could possibly affect
endothelial function.
Conclusion
Encapsulated fruit and vegetable concentrates did not
alter insulin or glucose measures. Acute endothelial dys-
function was not observed with glucose loading, mitigat-
ing against observable treatment effects. Further study
with more overt impairment of endothelial function is
warranted.
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